欧蒙 EUROIMMUN    
欧蒙医学实验诊断股份公司创建于1987年9月，现总部位于德国吕贝克市，在Groß Grönau，Rennersdorf和Pegnitz设有分部。欧蒙公司在加拿大（米西索加）、中国（北京，杭州）、英国（新港）、意大利（帕多瓦）、黎巴嫩（贝鲁特）、波兰（弗罗茨瓦夫）、瑞士（洛桑）、新加坡、南非（开普敦）、土耳其（伊斯坦布尔）、美国（新泽西州）设有分公司，现有员工近2000人。公司已取得ISO认证（EN ISO 9001:2000, EN ISO 13485:2003, ISO 13485/CMDCAS）。

欧蒙公司是医学实验诊断试剂的生产企业，在自身免疫性疾病、感染性疾病和变态反应性疾病的血清抗体检测领域位于世界前沿。欧蒙公司产品采用的实验方法主要有间接免疫荧光法、微孔板ELISA法、各种印迹技术（免疫印迹法、欧蒙斑点法、欧蒙印迹法和EUROLINE-WB）和分子生物学技术。基于已在全球范围获得专利的完美生产工艺和微量检测技术，欧蒙公司正成为医学实验诊断领域的世界领先制造商。

生物薄片（BIOCHIPs ）是欧蒙公司众多创新技术之一：将细胞或组织切片包被在极薄的盖玻片上，再用自动化机械将其切割成毫米大小的片段，随后用全自动的仪器将它们固定在载片上。这种生物薄片技术可使实验分析高度微量化和标准化。生物薄片马赛克（BIOCHIP Mosaics™）可将30种或更多的不同组织、细胞基质或性质明确的抗原（EUROPLUS™）进行组合，仅需要简单的实验温育，即可获得详尽的自身抗体谱信息。

欧蒙酶联免疫分析（ELISA）试剂采用经先进生物技术纯化的抗原作为检测基质，很多抗原是由欧蒙分子生物学实验室合成。欧蒙ELISA具有稳定性好、操作简单、温育时间短和适于自动化等优点。试剂盒中大多数成分可直接使用，并且不同批次之间可互换。欧蒙公司现可提供世界上最多种类的用于自身免疫性疾病和感染性疾病诊断的酶联免疫检测试剂。

欧蒙斑点法(EUROASSAY) 和欧蒙印迹法(EUROLINE)是欧蒙公司的革新技术。其遵循ELISA法的实验原理，并使用滴定平板技术和生物薄片技术：将纯化的抗原平行印在膜条上的指定位置。温育后，不需用其它设备就可目测结果。欧蒙斑点法和欧蒙印迹法特别适合于间接免疫荧光法中显微镜下不能确定的抗体分型，也适合于无精密实验设备的实验室使用。欧蒙公司还提供多种免疫印迹法试剂盒和相应试剂，用于确认免疫荧光法和ELISA的阳性结果以及自身免疫性疾病、感染性疾病和变态反应性疾病诊断中的疑难样本；并且，欧蒙已研发出新型电泳系统用于精确分离具有诊断意义的相关蛋白条带，同时提供批特异的参照膜条用于检测结果的分析。结果分析软件EURO­LineScan可使以膜为载体的检测系统实现结果的计算机自动判读，简化了大量标本的结果分析。

欧蒙公司卓越的技术优势不仅体现在生产和销售医学实验诊断产品上，也表现于公司参考实验室应用这些产品进行高级鉴别诊断上。此参考实验室建立了德国乃至世界范围内统一的自身免疫性疾病实验室检测标准。该实验室的检测项目还覆盖了感染性疾病和变态反应性疾病的血清学诊断，每天为来自德国和其它国家的上百份血清样品进行免费检测。这样不仅有助于欧蒙客户获得准确的实验结果，还保证了客户实验室的高水准。客户还可从公司的资深专家那里获得丰富的技术信息，并与他们就血清学领域中的问题进行深入讨论。欧蒙公司新成立了质量保证研究所，负责组织公正的质量评估并就质量管理中的问题提出建议。另外，欧蒙公司还建立了实验主要从事基础研究的免疫学研究所。

截止到2010年10月，欧蒙（德国）员工中有150名大学毕业生，他们中有生物学家、生化学家、化学家、工程师和临床医生（其中48人获得博士学位）。欧蒙还有103名与公司业务相应的医学技术人员和81名生物化学/化学实验室技术员。现在有55个年轻人在公司接受培训，他们将来承担生物实验室技术员、职员、IT专家、电子系统技师、仪器和系统电子技师和工程机械师等工作。

欧蒙公司致力于引导客户使用先进的技术，支持客户使用对诊断有帮助的产品，努力淡化商业行为。欧蒙产品的成功推广基于充满朝气并具有竞争力的销售团队、优质的信息资料、详细易读的产品说明书和在专业杂志上刊登富有科学性、普及性的广告宣传。公司使用最先进的编辑制作方法和数码成像系统自己制作各种宣传资料，重要的出版物和产品彩页已翻译成多种语言。欧蒙公司在互联网上的主页：www.euroimmun.com，欢迎全球朋友访问。

目前世界上已有3000多家实验室在使用欧蒙公司的产品，其中400多家在德国。欧蒙公司正日益发展壮大。尽管德国的诊断试剂市场停滞不前并且竞争激烈，但欧蒙公司仍保持强劲的发展势头。随着越来越多的产品销往世界各地，欧蒙在德国市场独树一帜。欧蒙的产品以其优秀品质占据着世界领先地位。

EUROIMMUN produces a wide range of reagents for medical laboratory diagnostics. The main focus is on test systems for antibodies in patient serum. These allow highly sensitive and specific diagnosis of autoimmune diseases, infectious diseases and allergies.

Test methods are predominantly indirect immunofluorescence, microplate ELISA, various blot techniques (Westernblot, EUROASSAY, EUROLINE, EUROLINE-WB), RIA and all molecular biology techniques. EUROIMMUN also offers a comprehensive range of automation solutions. With innovative and patented production methods and microanalysis techniques, EUROIMMUN is one of the world's leading manufacturers of medical laboratory diagnostics.

EUROIMMUN was founded in September 1987 and today has its headquarters in Luebeck, Germany. German branches are situated in Gross Groenau near Luebeck (Schleswig Holstein), Dassow (Mecklenburg-Western Pomerania), Rennersdorf (Upper Lusatia, Saxony) and in Pegnitz (Upper Franconia, Bavaria). Further EUROIMMUN AG subsidiaries can be found in Canada (Mississauga), China (Beijing, Hangzhou), Great Britain (Wimbledon), Italy (Padua), Poland (Wroc­­?aw), Switzerland (Lucerne), Singapore, South Africa (Cape­town), Brazil (Porto Alegre), Turkey (Istanbul) and the USA (New Jersey). At present EUROIMMUN has 944employees in Germany, 1311 worldwide. The company is ISO-certified (EN ISO 9001:2008, EN ISO 13485:2003/CMDCAS).

EUROIMMUN produces reagents for medical laboratory diagnostics. In the foreground are test systems for the determination of various antibodies in patient serum in the diagnosis of autoimmune diseases, infectious diseases and allergies. The test methods employed are predominantly indirect immunofluorescence, microplate ELISA, various blot techniques (Westernblot, EUROASSAY, EUROLINE, EUROLINE-WB) and all molecular biology techniques. The company is based on worldwide-patented state-of-the-art production methods and microanalysis techniques and is one of the world’s leading manu­facturers of medical laboratory diagnostics.

The BIOCHIPs are one of EUROIMMUN’s many inventions: paper-thin sheets of glass are coated with cells or tissue sections and then cut automatically into millimetre-sized fragments which are subsequently glued onto slides using a fully automated device. This BIOCHIP technology allows extreme miniaturization and standardization of immun­bio­chemical analyses. With BIOCHIP Mosaics™made from 30 or more different organ sections, cell substrates or defined antigens (EUROPLUS™) only mini­mum incubation efforts are necessary to obtain a detailed antibody profile.

In EUROIMMUN enzyme immunoassays (ELISAs) defined antigens, purified using state-of-the-art biotechnological processes, are employed as the antigen substrate. Some of these antigens are synthesized in the company’s molecular biology laboratories. EUROIMMUN ELISA are characterized by their excellent stability, simple handling and short incubation times, and they are ideal for automated use. All reagents are delivered ready-to-use and are exchangeable between different lots. EUROIMMUN offers the largest and most differentiated arsenal of enzyme immunoassays worldwide for the diagnosis of autoimmune and infectious diseases.

The innovative procedures EUROASSAY and EUROLINE developed by EUROIMMUN follow the same test principle as the ELISA methods, with the use of the BIOCHIP technology. At EUROIMMUN purified antigens are printed in parallel lines at defined positions on membrane strips. Following incubation, users can evaluate results visually without additional equipment. These reagents allow in particular the differentiation of antibodies that are not clearly defined microscopically by indirect immunofluorescence. EUROASSAY and EUROLINE are also em­ployed in laboratories where no sophisticated laboratory instruments are available. EUROIMMUN produces an extensive range of Westernblot strip test systems and corres­ponding reagents for confirmation of positive fluorescence and ELISA results as well as clarification of difficult-to-interpret results in autoimmune diagnostics, infectious serology and allergology. Refined electrophoretical processes have been developed to allow the precise separation of diagnostically relevant proteins from one another. Lot-specific evalu­ation templates are produced for the evaluation of band patterns. The program ”EURO­LineScan“ enables fully automated evaluation of membrane-based test systems and simplifies the archiving of results with large sample series.

One of the company’s main strengths is its technical expertise. This encompasses not just the manufacture and sale of medical laboratory diagnostics, but also the diagnostic application of the products in a reference laboratory which provides highly differential diagnostics. This reference laboratory has set standards in Germany, and worldwide is unequalled in the whole field of autoimmune diagnostics. The diagnostic spectrum of the laboratory also covers the areas of infectious serology and serological allergy diagnostics. The reference laboratory receives hundreds of serum samples daily from all over Germany as well as from many other countries. It helps EUROIMMUN customers to secure their results: a large proportion of serum samples sent to EUROIMMUN for evaluation are analysed free of charge in order to maintain high standards in the laboratories of EUROIMMUN customers. Customers can obtain further technical information from experienced scientists in the company, with whom they can also discuss serological problem cases. The “Institute for Quality Assurance”, an institution newly founded by EUROIMMUN, organises unbiased quality assessments and provides advice in the area of quality management. Moreover EUROIMMUN has established the “Institute for experimental Immunology”, which is engaged in basic research.

In October 2012 the EUROIMMUN workforce included 170 university and college graduates, among these biologists, biochemists, chemists, engineers and medical doctors (48 of them holding a doctor’s degree). Medical technicians are particularly strongly represented with 111 people, corresponding to EUROIMMUN’s activities, as well as biology/chemistry laboratory technicians (81). At present the company is training 51 young people as biology laboratory assistants, industrial clerks, office communication clerks, IT specialists, IT clerks, electronic system technicians, electronic technicians for devices and systems, industrial mechanics, cooks, computer scientists and business economists (dual system).

At EUROIMMUN great value is placed on advising customers and prospective customers in a factual, technical and commercially restrained manner and fully supporting them in the use of our diagnostically demanding products. EUROIMMUN products are backed by an energetic and competent sales force, qualified information material, didactic test instructions and scientifically based, but nevertheless understandable advertisements in technical journals. Advertising material is produced in-house using the latest desktop publishing methods, right up until the fully digitalised ready-for-exposure documents. The most important publications and posters are translated into many languages.

Over 3,000 laboratories worldwide use EUROIMMUN diagnostics: 400 of these are in Ger­many. The company’s development is shaped by continuous growth. Although the diagnostic market in Germany stagnated and has become particularly strongly competitive, EURO­IMMUN has been able to continue its strong expansion. The company is achieving an ever increasing independence from the German market, since more and more products are sold abroad. With their quality and standardization, EUROIMMUN products are capturing the leading position in the world.